Primary record
Cyclo[(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl]
- 库存
- 9,982 克
- 纯度
- 99.0 %
- CAS
- 26048-05-5
化合物标识与属性
- CAS
- 26048-05-5
- PubChem CID
- 105014
- SMILES
- CC(C)C1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC2=CC=CC=C2)C)C(C)C)CC3=CC=CC=C3)C)C(C)C)CC4=CC=CC=C4)C
- Canonical SMILES
- CC(C)C1OC(=O)C(Cc2ccccc2)N(C)C(=O)C(C(C)C)OC(=O)C(Cc2ccccc2)N(C)C(=O)C(C(C)C)OC(=O)C(Cc2ccccc2)N(C)C1=O
名称与同义词
- Beauvericin
- AC1L2XVW
- RefChem:1066232
- UNII-26S048LS2R
- SCHEMBL6452789
- 26048-05-5
- CHEMBL1977672
- Beauvericin, >=97% (HPLC)
- C45H57N3O9
- 2-AMINO-5-PHENOXYBENZOICACID
- CID105014
- NSC708472
- C45-H57-N3-O9
- NSC-708472
- NCI60_038416
- DB-046823
- FT-0602893
- J3.537.719K
- C11590
- cyclo(D-|A-Hydroxyisovaleryl-L-N-methyl-Phe)3
- Beauvericin, VETRANAL(TM), analytical standard
- Cyclo(D-??-Hydroxyisovaleryl-L-N-methyl-Phe)3
- 3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
- 1,13-Trioxa-4,10,16-triazacyclooctadecane, cyclic peptide deriv.
- N-Methylcyclo(L-Phe-D-Hmb-N-methyl-L-Phe-D-Hmb-N-methyl-L-Phe-D-Hmb-)
- (3S,6R,9S,12R,15S,18R)-3,9,15-Tribenzyl-4,10,16-trimethyl-6,12,18-tripropan-2-yl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
- 2,8,14-Triisopropyl-4,10,16-trimethyl-5,11,17-tribenzyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-3,6,9,12,15,18-hexaone
- 3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tris(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
- Cyclo(D-.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl-D~ -.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl-D-.alpha.-hydroxyisovaleryl-N-methyl-L-phenylalanyl)
- Cyclo[(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-phenylalanyl]